Please login to the form below
Myalept
This page shows the latest Myalept news and features for those working in and with pharma, biotech and healthcare.
R&D productivity takes off
For example, Amgen's Blincyto (blinatumomab) for a rare form of leukaemia has been priced at $178, 000 a year, while AZ's Myalept (metreleptin) for the ultra-rare metabolic disorder
Latest news
-
Nexium windfall lifts AZ in third quarter
Meanwhile, AZ also said it is selling Myalept (metreleptin), an approved drug for generalised lipodystrophy, to Aegerion Pharmaceuticals. ... The latter will pay $325m upfront to acquire the global rights to Myalept, subject to an existing distributor
-
FDA approves AZ’s fish oil drug
Epanova gets green light to reduce high levels of fat in the blood
-
AZ gets limited approval for metreleptin in US
First FDA-backed treatment for rare disease lipodystrophy. AstraZeneca's Myalept has become the first approved treatment for the rare disease lipodystrophy after getting a green light from the FDA. ... Myalept will be "a much-needed treatment option for
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
-
Health Consultant - Brand Comms
-
Competitive Salary
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Scientific Director – Medical Communications
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Account Director, Medical Education
-
Salary TBC
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Digital Account Director
-
Salary TBC
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
Subscribe to our email news alerts
- Where next in Alzheimer’s disease R&D?
- McCann Health bolsters European leadership team
- Biogen and Eisai pull plug on Alzheimer’s drug
- Novo uses voucher for speedy answer on oral semaglutide
- Is Orkambi deal close? Vertex meets again today with NHS England
- Amgen, Servier heart failure drug clears trial hurdle
PMHub
Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...
Latest intelligence
- Where next in Alzheimer’s disease R&D?
- How past failures and emerging biology are reshaping drug development...
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
- Genomics integration: can the NHS rise to the challenge?
- Experts gather to discuss the UK’s genomic landscape...
Quick links
Infographics
